Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EGR1
|
ENSG00000120738.7 | early growth response 1 |
EGR4
|
ENSG00000135625.6 | early growth response 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EGR4 | hg19_v2_chr2_-_73520667_73520833 | -0.15 | 4.2e-01 | Click! |
EGR1 | hg19_v2_chr5_+_137801160_137801179 | 0.06 | 7.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_109087906 | 2.69 |
ENST00000515500.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr6_+_15249128 | 2.68 |
ENST00000397311.3
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr11_-_64511789 | 2.66 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr6_+_12012536 | 2.54 |
ENST00000379388.2
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
chr11_-_46142948 | 2.44 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
chr15_+_74833518 | 2.31 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr1_+_43148625 | 2.28 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chr19_-_33793430 | 2.19 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr4_-_109087872 | 2.16 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
chr19_-_14201776 | 2.02 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr13_-_41635512 | 1.93 |
ENST00000405737.2
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
chr10_-_129924611 | 1.85 |
ENST00000368654.3
|
MKI67
|
marker of proliferation Ki-67 |
chr16_+_23847267 | 1.83 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr19_+_16435625 | 1.82 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr9_-_130742792 | 1.75 |
ENST00000373095.1
|
FAM102A
|
family with sequence similarity 102, member A |
chr16_+_23847355 | 1.73 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
chr5_-_142784101 | 1.72 |
ENST00000503201.1
ENST00000502892.1 |
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr17_+_75369400 | 1.70 |
ENST00000590059.1
|
SEPT9
|
septin 9 |
chr12_-_58240470 | 1.69 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chr2_-_98612379 | 1.64 |
ENST00000425805.2
|
TMEM131
|
transmembrane protein 131 |
chr17_+_6900201 | 1.60 |
ENST00000480801.1
|
ALOX12
|
arachidonate 12-lipoxygenase |
chr16_+_29817841 | 1.59 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr11_-_64512469 | 1.55 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr16_+_23847339 | 1.54 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr1_-_9189144 | 1.50 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
chr18_+_3449821 | 1.49 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr1_-_202129704 | 1.48 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr2_+_219433281 | 1.48 |
ENST00000273064.6
ENST00000509807.2 ENST00000542068.1 |
RQCD1
|
RCD1 required for cell differentiation1 homolog (S. pombe) |
chr1_-_25256368 | 1.45 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr16_+_53164956 | 1.42 |
ENST00000563410.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
chr1_-_92951607 | 1.41 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
chr12_+_49372251 | 1.39 |
ENST00000293549.3
|
WNT1
|
wingless-type MMTV integration site family, member 1 |
chr4_-_25864581 | 1.37 |
ENST00000399878.3
|
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr10_+_135043750 | 1.35 |
ENST00000304477.2
|
UTF1
|
undifferentiated embryonic cell transcription factor 1 |
chr11_+_3876859 | 1.35 |
ENST00000300737.4
|
STIM1
|
stromal interaction molecule 1 |
chr16_+_28943260 | 1.35 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr2_+_30454390 | 1.34 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr18_+_3449695 | 1.34 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr21_+_17102311 | 1.33 |
ENST00000285679.6
ENST00000351097.5 ENST00000285681.2 ENST00000400183.2 |
USP25
|
ubiquitin specific peptidase 25 |
chr19_-_3801789 | 1.31 |
ENST00000590849.1
ENST00000395045.2 |
MATK
|
megakaryocyte-associated tyrosine kinase |
chr5_+_133450365 | 1.31 |
ENST00000342854.5
ENST00000321603.6 ENST00000321584.4 ENST00000378564.1 ENST00000395029.1 |
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
chr2_-_128145498 | 1.30 |
ENST00000409179.2
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2 |
chr3_-_47823298 | 1.30 |
ENST00000254480.5
|
SMARCC1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
chr11_-_46142615 | 1.30 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
chr5_+_176853702 | 1.30 |
ENST00000507633.1
ENST00000393576.3 ENST00000355958.5 ENST00000528793.1 ENST00000512684.1 |
GRK6
|
G protein-coupled receptor kinase 6 |
chr11_+_124609742 | 1.29 |
ENST00000284292.6
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr8_-_57123815 | 1.28 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr3_-_108836945 | 1.27 |
ENST00000483760.1
|
MORC1
|
MORC family CW-type zinc finger 1 |
chr16_-_89007491 | 1.26 |
ENST00000327483.5
ENST00000564416.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr15_-_41408339 | 1.25 |
ENST00000401393.3
|
INO80
|
INO80 complex subunit |
chr5_+_176853669 | 1.25 |
ENST00000355472.5
|
GRK6
|
G protein-coupled receptor kinase 6 |
chr2_-_98612350 | 1.24 |
ENST00000186436.5
|
TMEM131
|
transmembrane protein 131 |
chr2_+_219724544 | 1.23 |
ENST00000233948.3
|
WNT6
|
wingless-type MMTV integration site family, member 6 |
chr22_-_30722912 | 1.22 |
ENST00000215790.7
|
TBC1D10A
|
TBC1 domain family, member 10A |
chr19_-_2050852 | 1.20 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr11_-_64545941 | 1.18 |
ENST00000377387.1
|
SF1
|
splicing factor 1 |
chr11_+_124609823 | 1.18 |
ENST00000412681.2
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr19_-_1652575 | 1.16 |
ENST00000587235.1
ENST00000262965.5 |
TCF3
|
transcription factor 3 |
chr16_+_30194916 | 1.15 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr1_-_38471156 | 1.15 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
chr19_-_41859814 | 1.15 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
chr15_+_41136216 | 1.14 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr21_+_44394742 | 1.13 |
ENST00000432907.2
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chr19_-_54693401 | 1.13 |
ENST00000338624.6
|
MBOAT7
|
membrane bound O-acyltransferase domain containing 7 |
chr17_+_54671047 | 1.12 |
ENST00000332822.4
|
NOG
|
noggin |
chr2_+_191513587 | 1.10 |
ENST00000416973.1
ENST00000426601.1 |
NAB1
|
NGFI-A binding protein 1 (EGR1 binding protein 1) |
chr1_+_161494036 | 1.09 |
ENST00000309758.4
|
HSPA6
|
heat shock 70kDa protein 6 (HSP70B') |
chr19_-_663147 | 1.08 |
ENST00000606702.1
|
RNF126
|
ring finger protein 126 |
chrX_-_46618490 | 1.07 |
ENST00000328306.4
|
SLC9A7
|
solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 |
chr15_-_64648273 | 1.05 |
ENST00000607537.1
ENST00000303052.7 ENST00000303032.6 |
CSNK1G1
|
casein kinase 1, gamma 1 |
chr11_-_64511575 | 1.04 |
ENST00000431822.1
ENST00000377486.3 ENST00000394432.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr2_-_219433014 | 1.04 |
ENST00000418019.1
ENST00000454775.1 ENST00000338465.5 ENST00000415516.1 ENST00000258399.3 |
USP37
|
ubiquitin specific peptidase 37 |
chr19_-_663171 | 1.04 |
ENST00000606896.1
ENST00000589762.2 |
RNF126
|
ring finger protein 126 |
chr11_-_62313090 | 1.04 |
ENST00000528508.1
ENST00000533365.1 |
AHNAK
|
AHNAK nucleoprotein |
chr15_-_41408409 | 1.04 |
ENST00000361937.3
|
INO80
|
INO80 complex subunit |
chr1_+_226250379 | 1.04 |
ENST00000366815.3
ENST00000366814.3 |
H3F3A
|
H3 histone, family 3A |
chr6_+_12012170 | 1.02 |
ENST00000487103.1
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
chr11_-_64512803 | 1.02 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr15_+_86087267 | 1.02 |
ENST00000558166.1
|
AKAP13
|
A kinase (PRKA) anchor protein 13 |
chr5_-_140998616 | 1.00 |
ENST00000389054.3
ENST00000398562.2 ENST00000389057.5 ENST00000398566.3 ENST00000398557.4 ENST00000253811.6 |
DIAPH1
|
diaphanous-related formin 1 |
chrX_-_48814278 | 0.99 |
ENST00000455452.1
|
OTUD5
|
OTU domain containing 5 |
chr20_+_35202909 | 0.99 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
chr1_-_183604794 | 0.99 |
ENST00000367534.1
ENST00000359856.6 ENST00000294742.6 |
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa |
chr1_+_150122034 | 0.97 |
ENST00000025469.6
ENST00000369124.4 |
PLEKHO1
|
pleckstrin homology domain containing, family O member 1 |
chr9_+_127020202 | 0.96 |
ENST00000373600.3
ENST00000320246.5 |
NEK6
|
NIMA-related kinase 6 |
chr20_-_3996165 | 0.96 |
ENST00000545616.2
ENST00000358395.6 |
RNF24
|
ring finger protein 24 |
chr6_+_144471643 | 0.95 |
ENST00000367568.4
|
STX11
|
syntaxin 11 |
chr4_-_36245561 | 0.95 |
ENST00000506189.1
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr20_+_34894247 | 0.95 |
ENST00000373913.3
|
DLGAP4
|
discs, large (Drosophila) homolog-associated protein 4 |
chr15_-_80263506 | 0.94 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr19_-_663277 | 0.94 |
ENST00000292363.5
|
RNF126
|
ring finger protein 126 |
chr11_+_73087309 | 0.94 |
ENST00000064780.2
ENST00000545687.1 |
RELT
|
RELT tumor necrosis factor receptor |
chr12_+_105724613 | 0.94 |
ENST00000549934.2
|
C12orf75
|
chromosome 12 open reading frame 75 |
chr4_-_78740511 | 0.93 |
ENST00000504123.1
ENST00000264903.4 ENST00000515441.1 |
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
chr7_+_18126557 | 0.93 |
ENST00000417496.2
|
HDAC9
|
histone deacetylase 9 |
chr3_-_135915146 | 0.93 |
ENST00000473093.1
|
MSL2
|
male-specific lethal 2 homolog (Drosophila) |
chr11_-_46142505 | 0.92 |
ENST00000524497.1
ENST00000418153.2 |
PHF21A
|
PHD finger protein 21A |
chr4_+_154387480 | 0.92 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
chr17_-_7297833 | 0.92 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr12_-_24715307 | 0.91 |
ENST00000538905.1
|
RP11-444D3.1
|
RP11-444D3.1 |
chr18_+_2655849 | 0.91 |
ENST00000261598.8
|
SMCHD1
|
structural maintenance of chromosomes flexible hinge domain containing 1 |
chr22_-_30722866 | 0.91 |
ENST00000403477.3
|
TBC1D10A
|
TBC1 domain family, member 10A |
chr4_+_38665810 | 0.90 |
ENST00000261438.5
ENST00000514033.1 |
KLF3
|
Kruppel-like factor 3 (basic) |
chr15_+_75494214 | 0.90 |
ENST00000394987.4
|
C15orf39
|
chromosome 15 open reading frame 39 |
chr6_+_138188351 | 0.89 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr16_-_70472946 | 0.89 |
ENST00000342907.2
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr11_-_66104237 | 0.89 |
ENST00000530056.1
|
RIN1
|
Ras and Rab interactor 1 |
chr6_+_31543334 | 0.89 |
ENST00000449264.2
|
TNF
|
tumor necrosis factor |
chr12_-_46385811 | 0.89 |
ENST00000419565.2
|
SCAF11
|
SR-related CTD-associated factor 11 |
chr17_-_47439437 | 0.88 |
ENST00000430262.2
|
ZNF652
|
zinc finger protein 652 |
chr1_+_21835858 | 0.88 |
ENST00000539907.1
ENST00000540617.1 ENST00000374840.3 |
ALPL
|
alkaline phosphatase, liver/bone/kidney |
chr16_+_50313426 | 0.88 |
ENST00000569265.1
|
ADCY7
|
adenylate cyclase 7 |
chr17_-_7297519 | 0.88 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chrX_+_131157322 | 0.88 |
ENST00000481105.1
ENST00000354719.6 ENST00000394335.2 |
MST4
|
Serine/threonine-protein kinase MST4 |
chrX_-_129402857 | 0.88 |
ENST00000447817.1
ENST00000370978.4 |
ZNF280C
|
zinc finger protein 280C |
chr1_-_1149506 | 0.87 |
ENST00000379236.3
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4 |
chr10_+_6625605 | 0.87 |
ENST00000414894.1
ENST00000449648.1 |
PRKCQ-AS1
|
PRKCQ antisense RNA 1 |
chr8_+_128747661 | 0.87 |
ENST00000259523.6
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr19_+_56154913 | 0.86 |
ENST00000270451.5
ENST00000588537.1 |
ZNF581
|
zinc finger protein 581 |
chr15_-_38852251 | 0.86 |
ENST00000558432.1
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chr12_+_54379569 | 0.86 |
ENST00000513209.1
|
RP11-834C11.12
|
RP11-834C11.12 |
chr5_-_140998481 | 0.86 |
ENST00000518047.1
|
DIAPH1
|
diaphanous-related formin 1 |
chr3_-_135915401 | 0.85 |
ENST00000491050.1
|
MSL2
|
male-specific lethal 2 homolog (Drosophila) |
chr16_+_50776021 | 0.85 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr11_-_64512273 | 0.85 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr17_-_36413133 | 0.85 |
ENST00000523089.1
ENST00000312412.4 ENST00000520237.1 |
RP11-1407O15.2
|
TBC1 domain family member 3 |
chr5_-_142783694 | 0.84 |
ENST00000394466.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr4_-_185395191 | 0.84 |
ENST00000510814.1
ENST00000507523.1 ENST00000506230.1 |
IRF2
|
interferon regulatory factor 2 |
chr8_-_144679833 | 0.84 |
ENST00000419152.2
ENST00000423316.2 ENST00000395119.3 ENST00000529272.1 |
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
chr13_-_45915221 | 0.84 |
ENST00000309246.5
ENST00000379060.4 ENST00000379055.1 ENST00000527226.1 ENST00000379056.1 |
TPT1
|
tumor protein, translationally-controlled 1 |
chr6_+_135502466 | 0.84 |
ENST00000367814.4
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr6_-_2876744 | 0.83 |
ENST00000420981.2
|
RP11-420G6.4
|
RP11-420G6.4 |
chrX_+_131157290 | 0.83 |
ENST00000394334.2
|
MST4
|
Serine/threonine-protein kinase MST4 |
chr4_-_78740769 | 0.83 |
ENST00000512485.1
|
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
chr18_+_2655692 | 0.82 |
ENST00000320876.6
|
SMCHD1
|
structural maintenance of chromosomes flexible hinge domain containing 1 |
chr3_+_152879985 | 0.82 |
ENST00000323534.2
|
RAP2B
|
RAP2B, member of RAS oncogene family |
chr17_-_42462688 | 0.81 |
ENST00000377068.3
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
chr12_-_53625958 | 0.81 |
ENST00000327550.3
ENST00000546717.1 ENST00000425354.2 ENST00000394426.1 |
RARG
|
retinoic acid receptor, gamma |
chr15_+_41136263 | 0.81 |
ENST00000568823.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr19_-_54693521 | 0.81 |
ENST00000391754.1
ENST00000245615.1 ENST00000431666.2 |
MBOAT7
|
membrane bound O-acyltransferase domain containing 7 |
chr3_+_196366555 | 0.79 |
ENST00000328557.4
|
NRROS
|
negative regulator of reactive oxygen species |
chr2_+_232573208 | 0.79 |
ENST00000409115.3
|
PTMA
|
prothymosin, alpha |
chr4_+_57774042 | 0.79 |
ENST00000309042.7
|
REST
|
RE1-silencing transcription factor |
chr3_-_135916073 | 0.79 |
ENST00000481989.1
|
MSL2
|
male-specific lethal 2 homolog (Drosophila) |
chr8_+_32405728 | 0.78 |
ENST00000523079.1
ENST00000338921.4 ENST00000356819.4 ENST00000287845.5 ENST00000341377.5 |
NRG1
|
neuregulin 1 |
chr8_+_61822605 | 0.78 |
ENST00000526936.1
|
AC022182.1
|
AC022182.1 |
chr4_+_26322987 | 0.78 |
ENST00000505958.1
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr1_-_156786634 | 0.78 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
chr4_-_36246060 | 0.78 |
ENST00000303965.4
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr3_-_108836977 | 0.78 |
ENST00000232603.5
|
MORC1
|
MORC family CW-type zinc finger 1 |
chr1_+_26606608 | 0.77 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr2_-_192015697 | 0.77 |
ENST00000409995.1
|
STAT4
|
signal transducer and activator of transcription 4 |
chr5_-_142784003 | 0.77 |
ENST00000416954.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr19_-_15443318 | 0.76 |
ENST00000360016.5
|
BRD4
|
bromodomain containing 4 |
chrX_-_48776292 | 0.76 |
ENST00000376509.4
|
PIM2
|
pim-2 oncogene |
chr3_-_52273098 | 0.76 |
ENST00000499914.2
ENST00000305533.5 ENST00000597542.1 |
TWF2
TLR9
|
twinfilin actin-binding protein 2 toll-like receptor 9 |
chr5_-_176924562 | 0.76 |
ENST00000359895.2
ENST00000355572.2 ENST00000355841.2 ENST00000393551.1 ENST00000505074.1 ENST00000356618.4 ENST00000393546.4 |
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr9_+_137218362 | 0.76 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
chr6_+_138188378 | 0.75 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr3_-_88108212 | 0.75 |
ENST00000482016.1
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
chr7_-_139876812 | 0.75 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr2_-_214016314 | 0.74 |
ENST00000434687.1
ENST00000374319.4 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr22_+_50354104 | 0.74 |
ENST00000360612.4
|
PIM3
|
pim-3 oncogene |
chr1_+_212458834 | 0.74 |
ENST00000261461.2
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha |
chr19_-_54693146 | 0.74 |
ENST00000414665.1
ENST00000453320.1 |
MBOAT7
|
membrane bound O-acyltransferase domain containing 7 |
chrX_-_154033686 | 0.74 |
ENST00000453245.1
ENST00000428488.1 ENST00000369531.1 |
MPP1
|
membrane protein, palmitoylated 1, 55kDa |
chr15_+_39873268 | 0.74 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr14_-_67982146 | 0.74 |
ENST00000557779.1
ENST00000557006.1 |
TMEM229B
|
transmembrane protein 229B |
chr19_-_12777509 | 0.73 |
ENST00000221363.4
ENST00000598876.1 ENST00000456935.2 ENST00000486847.2 |
MAN2B1
|
mannosidase, alpha, class 2B, member 1 |
chr3_+_14989186 | 0.73 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr16_+_28834303 | 0.73 |
ENST00000340394.8
ENST00000325215.6 ENST00000395547.2 ENST00000336783.4 ENST00000382686.4 ENST00000564304.1 |
ATXN2L
|
ataxin 2-like |
chrX_+_131157609 | 0.73 |
ENST00000496850.1
|
MST4
|
Serine/threonine-protein kinase MST4 |
chr9_+_100745615 | 0.72 |
ENST00000339399.4
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
chr21_+_44394620 | 0.72 |
ENST00000291547.5
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chr17_-_18945798 | 0.72 |
ENST00000395635.1
|
GRAP
|
GRB2-related adaptor protein |
chr14_+_23352374 | 0.72 |
ENST00000267396.4
ENST00000536884.1 |
REM2
|
RAS (RAD and GEM)-like GTP binding 2 |
chrX_-_108976410 | 0.72 |
ENST00000504980.1
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4 |
chr19_-_44174330 | 0.72 |
ENST00000340093.3
|
PLAUR
|
plasminogen activator, urokinase receptor |
chr5_+_109025067 | 0.71 |
ENST00000261483.4
|
MAN2A1
|
mannosidase, alpha, class 2A, member 1 |
chr14_-_67981916 | 0.71 |
ENST00000357461.2
|
TMEM229B
|
transmembrane protein 229B |
chr19_+_54372693 | 0.71 |
ENST00000391768.2
|
MYADM
|
myeloid-associated differentiation marker |
chrX_-_154033793 | 0.71 |
ENST00000369534.3
ENST00000413259.3 |
MPP1
|
membrane protein, palmitoylated 1, 55kDa |
chr11_-_72853267 | 0.71 |
ENST00000409418.4
|
FCHSD2
|
FCH and double SH3 domains 2 |
chr2_+_69002052 | 0.70 |
ENST00000497079.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr11_-_66103932 | 0.70 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
chr12_+_53774423 | 0.69 |
ENST00000426431.2
|
SP1
|
Sp1 transcription factor |
chr2_-_225907150 | 0.69 |
ENST00000258390.7
|
DOCK10
|
dedicator of cytokinesis 10 |
chr12_-_111126910 | 0.69 |
ENST00000242607.8
|
HVCN1
|
hydrogen voltage-gated channel 1 |
chr8_+_22019168 | 0.68 |
ENST00000318561.3
ENST00000521315.1 ENST00000437090.2 ENST00000520605.1 ENST00000522109.1 ENST00000524255.1 ENST00000523296.1 ENST00000518615.1 |
SFTPC
|
surfactant protein C |
chr1_-_33647267 | 0.68 |
ENST00000291416.5
|
TRIM62
|
tripartite motif containing 62 |
chr6_+_36164487 | 0.68 |
ENST00000357641.6
|
BRPF3
|
bromodomain and PHD finger containing, 3 |
chr19_+_54372877 | 0.67 |
ENST00000414489.1
|
MYADM
|
myeloid-associated differentiation marker |
chr15_-_78369994 | 0.67 |
ENST00000300584.3
ENST00000409931.3 |
TBC1D2B
|
TBC1 domain family, member 2B |
chr6_-_112194484 | 0.67 |
ENST00000518295.1
ENST00000484067.2 ENST00000229470.5 ENST00000356013.2 ENST00000368678.4 ENST00000523238.1 ENST00000354650.3 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr1_-_156786530 | 0.67 |
ENST00000368198.3
|
SH2D2A
|
SH2 domain containing 2A |
chr14_+_64971438 | 0.67 |
ENST00000555321.1
|
ZBTB1
|
zinc finger and BTB domain containing 1 |
chr14_-_53619816 | 0.67 |
ENST00000323669.5
ENST00000395606.1 ENST00000357758.3 |
DDHD1
|
DDHD domain containing 1 |
chr17_+_36858694 | 0.67 |
ENST00000563897.1
|
CTB-58E17.1
|
CTB-58E17.1 |
chr12_-_96794330 | 0.67 |
ENST00000261211.3
|
CDK17
|
cyclin-dependent kinase 17 |
chr2_+_69001913 | 0.67 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
1.0 | 3.1 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.7 | 2.2 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.7 | 4.8 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 1.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.5 | 1.6 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.5 | 1.4 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.5 | 2.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 1.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 1.6 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.4 | 1.2 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.4 | 0.8 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 1.1 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.4 | 1.5 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.4 | 1.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 1.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 4.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 1.3 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.3 | 0.9 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 2.0 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.3 | 0.9 | GO:1901656 | glycoside transport(GO:1901656) |
0.3 | 1.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 3.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 1.0 | GO:0060623 | pericentric heterochromatin assembly(GO:0031508) regulation of chromosome condensation(GO:0060623) |
0.3 | 2.5 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.2 | 0.5 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.2 | 0.7 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.2 | 0.7 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.2 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 2.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 2.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 1.2 | GO:0032796 | uropod organization(GO:0032796) |
0.2 | 1.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 1.3 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.7 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.2 | 1.5 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.2 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 2.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.6 | GO:0071262 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
0.2 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 0.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 1.0 | GO:0021769 | orbitofrontal cortex development(GO:0021769) |
0.2 | 1.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.8 | GO:1901895 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.2 | 0.9 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.2 | 1.3 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 2.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 0.9 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.2 | 0.5 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.2 | 2.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 1.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 0.8 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 0.2 | GO:0071506 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) |
0.2 | 2.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.3 | GO:1905068 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.2 | 0.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.2 | 0.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.2 | 2.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 3.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 2.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 1.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.2 | 1.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 3.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 1.0 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.1 | 2.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 1.2 | GO:0002326 | B cell lineage commitment(GO:0002326) immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.9 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.6 | GO:0019482 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) |
0.1 | 0.6 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.8 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.1 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.4 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 0.4 | GO:0070377 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.1 | 0.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.1 | 0.4 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.6 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.1 | 0.5 | GO:0065001 | negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
0.1 | 1.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.9 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 1.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 0.6 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.1 | 0.4 | GO:0003192 | mitral valve formation(GO:0003192) |
0.1 | 1.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 1.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.1 | 0.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 1.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.5 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.3 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.1 | 0.1 | GO:0009451 | RNA modification(GO:0009451) |
0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 0.4 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.1 | 0.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 3.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.4 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 0.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.1 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.4 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.4 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.3 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
0.1 | 0.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.7 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.2 | GO:1902824 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.7 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.6 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) |
0.1 | 0.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.1 | 1.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.2 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.1 | 0.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 0.3 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) oncogene-induced cell senescence(GO:0090402) positive regulation of cellular response to X-ray(GO:2000685) |
0.1 | 3.2 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.6 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.3 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.1 | 0.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 1.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.4 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 1.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 1.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.6 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 2.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.1 | 0.3 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.7 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
0.1 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.5 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.6 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.6 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 1.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.1 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.5 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.0 | 0.4 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.9 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 1.0 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 5.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.9 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.3 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.0 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 1.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.0 | 0.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 2.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 1.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 1.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 1.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 3.9 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 1.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.0 | 0.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.3 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.2 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.0 | 0.2 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 1.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 5.0 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.0 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.3 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.1 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.0 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 4.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.3 | GO:0071107 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.7 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.0 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.8 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.0 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0003335 | corneocyte development(GO:0003335) |
0.0 | 0.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 1.2 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.6 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 1.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.2 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:2000825 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.2 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.0 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 1.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.4 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.2 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 1.7 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.1 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 0.4 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 1.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.5 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 1.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.0 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 1.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 2.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 1.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.0 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.5 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 1.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 1.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.4 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.2 | GO:0001756 |